Revolutionizing C. difficile Prevention
- September 15, 2025
- Latest News
A first-of-its-kind microbiome-based platform for C. difficile relapse prevention - proven, patent-protected, and ready for food & pharma partners.
Read MoreA first-of-its-kind microbiome-based platform for C. difficile relapse prevention - proven, patent-protected, and ready for food & pharma partners.
Read MoreSporeGen® signed a MOU with FG-Systems in Berlin to work together on developing new animal feed products, probiotics and animal vaccines.
Read MoreSporeGen® has been successful on a collaborative research grant focused on animal feeds and led by Dr T. Alexander (Lethbridge, Alberta) funded by Agriculture and Agri-Food Canada.
Read More